News
The shift was a marked departure from previous FDA guidance, which recommended an annual COVID vaccine for everyone 6 months ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results